"New breakthrough in the industrialization of a traditional Chinese medicine, Shenyi Capsules, and new clinical application research on its anti-tumor mechanism" won the first prize of Jilin Provincial Science and Technology Progress Award

The research on forsythin as a COVID-19 drug has received support from Dalian‘s major project announcement and leadership initiative

FS16 obtained the approval for Phase II clinical trials from the US FDA

"The application of high-efficiency preparation technology and mechanism of action research for ginseng in product development" won the second prize of Liaoning Provincial Technical Invention Award. The antiviral class I new drug "forsythin" and "forsythin capsule" have entered the second ...

Dr. Fuli was awarded the "Outstanding Contribution to Traditional Chinese Medicine Technology Innovation" award

The core technology and significant achievements in the application of a new drug class, ginsenoside Rg3, have been awarded the "China Patent Excellence Award"

The core technology and significant achievements in the application of a new drug class, ginsenoside Rg3, have been awarded the Liaoning Provincial Enterprise Major R&D Achievement Award, and have been approved by the Dalian Science and Technology Bureau to form part of the "Dalian Biomedical Industry Technolo...

The "Dalian Fusheng Traditional Chinese Medicine Monomer Raw Materials and Preparation Technology Platform" was approved to be established by the Science and Technology Bureau of Jinzhou New Area. The core technology and significant achievements in the application of new drugs such as ginsenoside Rg3 have bee...

The "Dalian Fusheng Traditional Chinese Medicine Monomer Raw Materials and Preparation Technology Platform" was approved to be established by the Science and Technology Bureau of Jinzhou New Area. The core technology and significant achievements in the application of new drugs such as ginsenoside Rg3 have bee...

Recognized as a national-level enterprise postdoctoral research station by the Ministry of Human Resources and Social Security of China

Recognized as a national-level enterprise postdoctoral research station by the Ministry of Human Resources and Social Security of China

The Science and Technology Bureau of Jinzhou New Area (formerly Dalian Development Zone) has approved the establishment of the "Dalian Development Zone Traditional Chinese Medicine Monomer Raw Materials and Preparation Engineering Research Center"

The Liaoning Provincial Science and Technology Department has approved the establishment of the "Liaoning Provincial Engineering Research Center for Chinese Medicine Monomer Raw Materials and Preparations"

The Dalian Municipal Development and Reform Commission has approved the establishment of the "Dalian Traditional Chinese Medicine Monomer Raw Materials and Preparation Engineering Research Center". The "National Key New Product" certificate for Ginsenoside Rg3-Shenbaiyi Capsules was jointly issued b...

Recognized as a provincial postdoctoral research base for private enterprises by the Liaoning Provincial Department of Human Resources and Social Security

Established Dalian Fusheng Pharmaceutical Co., Ltd., with a registered capital of 30.61 million yuan

Establish Dalian Fusheng Natural Medicine Development Co., Ltd., with a registered capital of 15 million yuan

Obtained the "New Drug Certificate" for the ginsenoside Rg3 raw material and oral preparation "Shenyi Capsules" as well as the production approval for Class I traditional Chinese medicine from the National Medical Products Administration

Establish a joint venture company - Jilin Yatai Pharmaceutical Co., Ltd., with a registered capital of 58.82 million yuan and a 49% technical share

Founded Dalian Tianfu Technology Development Co., Ltd., with a registered capital of 1 million yuan